PortfoliosStock ScreensStocksStockXcel

Dermata Therapeutics Inc. Common Stock

DRMA | US

1.33

USD

0.08

6.40%

DRMA | US

About Dermata Therapeutics Inc. Common Stock

Sector

Healthcare

Industry

Biotechnology

Earnings date

30/06/2024

As of date

09/03/2026

Close

1.33

Open

1.25

High

1.33

Low

1.24

Dermata Therapeutics Inc. a clinical-stage medical dermatology company focuses on identifying developing and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310 which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of hyperhidrosis and aesthetic conditions. Dermata Therapeutics Inc. was incorporated in 2014 and is headquartered in San Diego California.

View Less

DRMA | US

Risk
232.0
Sharpe
-0.79
Luna's Score
46/100
Recommendation
Hold

Luna says (DRMA | US)

What's Working

Low Market Beta (-0.4 to 0.8)

Value Stock (Price to Book < 3)

What's not Working

High 6-Month Volatility (>65%)

Microcap (<300M USD)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

10 days

63.3%

1 month

232.0%

3 months

196.0%

6 months

152.3%

Returns

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

0.73

Debt to equity

-

Debt to assets

-

Ent. to EBITDA

0.58

Ent. to rev.

-

PEG

-

Other Fundamentals

EBITDA

-7.86M

MarketCap

2.01M

MarketCap(USD)

2.01M

Div. yield

-

Op. margin

-

Erngs. growth

-

Rev. growth

-

Ret. on equity

-173.01

Short ratio

0.05

Short perc.

4.63

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bearish (SMA6M < SMA12M)

SMAs: Stock Price Trends

Range10D

0.22

Range1M

1.18

Range3M

3.55

Volumes: Market Activity

Rel. volume

0.08

Price X volume

225.15K

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
CARMCARMBiotechnology0.0441.83M6.02%n/a1044.17%
Allarity Therapeutics Inc. Common StockALLRBiotechnology1.241.75M0.00%n/a6.68%
Plus Therapeutics IncPSTVBiotechnology0.29521.74M2.25%n/a-45.04%
BioRestorative Therapies IncBRTXBiotechnology0.2321.61M8.97%n/a0.77%
Lipella Pharmaceuticals Inc. Common StockLIPOBiotechnology0.1941.57M25.08%n/a5.50%
Azitra IncAZTRBiotechnology0.2031.55M12.53%0.0141.86%
ERNAERNABiotechnology0.2831.53M-0.70%n/a-577.12%
Kala Pharmaceuticals IncKALABiotechnology0.26051.43M-6.33%n/a268.29%
International Stem Cell CorporationISCOBiotechnology0.17611.41Mn/a0.00%
XORTX Therapeutics Inc. Common StockXRTXBiotechnology0.45991.38M-1.88%n/a3.09%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Vision Marine Technologies IncVMARRecreational Vehicles2.461.36M2.93%n/a0.00%
Micromobility.com Inc.MCOMRecreational Vehicles0.008737.72Kn/a-37.05%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA0.580.53Par
Ent. to Revenue-3,967.00-
PE Ratio-41.03-
Price to Book0.7315.55Cheaper
Dividend Yield-2.20-
Std. Deviation (3M)195.9972.80Riskier
Debt to Equity--1.23-
Debt to Assets-0.25-
Market Cap2.01M3.66BEmerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007